Douglas E. Williams, EVP Research & Development at BIOGEN IDEC INC. (BIIB), sold 4,368 shares at $211.35 ($923K) on 2013-08-26, disclosed to the SEC on 2013-08-28.
Scheduled sale ($923k) by EVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CDAK | SELL | 2023-01-23 | $3K | — | Filing → |
| OVID | BUY | 2018-08-16 | $32K | — | Filing → |
| BIIB | SELL | 2015-06-22 | $1.6M | — | Filing → |